Hideki Sakai

Papers

Total Citations

H-Index

About

Dr. Hideki Sakai is a leading urologic oncologist whose research focuses on improving outcomes for high-risk prostate cancer (PCa) patients. His most cited work, a 2022 study, rigorously evaluates preoperative predictors of pathological lymph node (LN) metastasis and biochemical recurrence (BCR) following robot-assisted radical prostatectomy with extended pelvic LN dissection. By identifying key clinical and pathological factors that forecast aggressive disease, Dr. Sakai’s research directly informs surgical decision-making and risk stratification for D’Amico high-risk PCa patients. This study has garnered 12 citations, reflecting its practical impact on urologic oncology. Beyond this landmark paper, Dr. Sakai’s broader contributions encompass refining surgical techniques and prognostic models to enhance long-term cancer control. His work bridges the gap between preoperative assessment and postoperative outcomes, offering clinicians evidence-based tools to personalize treatment. For students and researchers, Dr. Sakai exemplifies how targeted, clinically relevant research can translate into tangible improvements in patient care, making him a respected voice in the fight against high-risk prostate cancer.